The fate of drug discovery in academia: Why is it so difficult?
A new editorial paper titled "The fate of drug discovery in academia; dumping in the publication landfill?" has been published in Oncotarget.
Feb 5, 2024
0
0
A new editorial paper titled "The fate of drug discovery in academia; dumping in the publication landfill?" has been published in Oncotarget.
Feb 5, 2024
0
0
Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical ...
Dec 14, 2023
0
0
For a long time, we've relied on animal testing to advance human health. It's been considered necessary to develop new and effective medical treatments that save human lives. But what if we could reduce or even eliminate ...
Oct 24, 2023
0
0
Researchers at Oregon State University have created a means of speeding up and improving the evaluation process for drugs used to combat cervical cancer.
Mar 31, 2023
0
19
A National Institutes of Health team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 ...
Mar 29, 2023
0
7
New research from VCU Massey Cancer Center published Thursday in Cell Reports has demonstrated that a novel targeted therapy could be an effective treatment option for a deadly pediatric cancer known as neuroblastoma.
Jul 28, 2022
0
27
As part of ongoing efforts to make a live attenuated vaccine for COVID-19, Texas Biomedical Research Institute Professor Luis Martinez-Sobrido and his team developed a weakened, or attenuated, version of SARS-CoV-2 that does ...
Jul 21, 2022
0
7
A McMaster researcher is part of a team that has developed a more efficient way to screen for vitamin D deficiency that could become a tool in the fight against COVID-19 and other respiratory illnesses.
Apr 15, 2022
0
50
A research team led by Prof. Liu Qingsong and Liu Jing from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) has recently found that nintedanib, a multikinase inhibitor of the receptor ...
Apr 7, 2022
0
30
It takes 10 to 15 years and around US$1 billion to develop one successful drug. Despite these significant investments in time and money, 90% of drug candidates in clinical trials fail. Whether because they don't adequately ...
Feb 24, 2022
0
15